Article info
PDFPostScript
Letters
CSF biomarker utilisation and ethical considerations of biomarker assisted diagnosis and research in dementia: perspectives from within the European Alzheimer’s Disease Consortium (EADC)
- Correspondence to Dr M Olde Rikkert, Department of Geriatric Medicine, 925, Radboud University Nijmegen Medical Centre, PO Box 9101, 6500 HB Nijmegen, The Netherlands; M.Olde-Rikkert{at}ger.umcn.nl
Citation
CSF biomarker utilisation and ethical considerations of biomarker assisted diagnosis and research in dementia: perspectives from within the European Alzheimer’s Disease Consortium (EADC)
Publication history
- Received February 26, 2009
- Accepted April 22, 2009
- First published December 17, 2009.
Online issue publication
April 13, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
BMJ Publishing Group Ltd. All rights reserved.